Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, as it prepares to launch its popular ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...

Eli Lilly (LLY) stock is higher Thursday after ... According to S&P Global Market Intelligence, the consensus analyst target price for LLY stock is $975.09, representing implied upside of about ...

With its 2-star rating, we believe Eli Lilly’s stock is over-valued compared to ... receiving branded GLP-1 therapies. We think US prices could fall substantially as volumes increase (in line ...

Given recent price action, a buy-the-dip scenario could ... marking a staggering 32% growth at the midpoint. Eli Lilly’s stock dipped after its Q4 guidance came in lower than expected.